<DOC>
	<DOC>NCT00238654</DOC>
	<brief_summary>This study has patients responding to two sets of surveys that will tell their doctor or nurse about their readiness to begin self-injection. In addition, patients will have their self-injection observed and evaluated on up to three visits</brief_summary>
	<brief_title>A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to CopaxoneÂ® Therapy</brief_title>
	<detailed_description />
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Glatiramer Acetate</mesh_term>
	<criteria>1. Male or Female, 18 years of age or older, with diagnosis of RRMS 2. Naive to treatment or previously treated with an IFN. 1. Not eligible for treatment based on clinical criteria and current indication. 2. Unable to respond to surveys or provide informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
</DOC>